Description:Montelukast Acyl-β-D-glucuronide is a metabolite of Montelukast, a leukotriene receptor antagonist primarily used in the management of asthma and allergic rhinitis. This compound is characterized by its glucuronidation, a common phase II metabolic process where a glucuronic acid moiety is conjugated to a drug or its metabolite, enhancing its solubility and facilitating excretion. The structure of Montelukast Acyl-β-D-glucuronide includes a glucuronic acid unit linked to the Montelukast molecule, which contributes to its pharmacokinetic properties. This metabolite is generally less active than the parent compound but may still play a role in the overall therapeutic effects and safety profile of Montelukast. Its solubility in water is increased due to the glucuronide formation, which aids in renal excretion. Understanding the characteristics of this metabolite is crucial for evaluating the drug's metabolism, efficacy, and potential side effects in clinical settings.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![β-D-Glucopyranuronic acid, 1-[1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(…](https://static.cymitquimica.com/products/IN/thumb/DA002H75.jpg)
